Hậu Giang Pharmaceutical Joint Stock Company (DHG), one of the leading companies in the pharmaceutical cosmetics industry, recorded profit of VNĐ190 billion (US$4.3 million) in the second quarter of this year, up 6 per cent on-year.
The company earned VNĐ933 billion in revenue during the period.
In the second quarter, sales increased by VNĐ31 billion compared to the same period last year to VNĐ182 billion. Advertising costs rose VNĐ20 billion to VNĐ36.4 billion, while employee costs also increased by VNĐ11 billion.
Corporate expenses were down by VNĐ18 billion to VNĐ68.7 billion.
In the first half of this year, DHG made revenue of VNĐ1.84 trillion, up slightly from the VNĐ1.80 trillion recorded in the same period last year and equivalent to 42 per cent of this year’s target.
Pre-tax profit during the first half was VNĐ360.7 billion, completing 44 per cent of the annual target. Post-tax profit reached VNĐ310 billion, down 14 per cent year-on-year.
By the end of the second quarter, inventory stood at VNĐ780 billion, up VNĐ147 billion compared to the beginning of the year. DHG also posted bad debt of more than VNĐ216 billion. — VNS
Read original article here